High-dose radioimmunotherapy/chemotherapy and autologous stem cell transplantation (ASCT) for poor risk and relapsed CD20+non-Hodgkin's lymphoma (NHL): Early feasibility report.

被引：0
作者：
Raubitschek, A
Nademanee, A
Molina, A
Rodriguez, R
White, C
Forman, S
机构：
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[2] Idec Pharmaceut Corp, San Diego, CA USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5372
引用
收藏
页码：374B / 375B
页数：2
相关论文
共 50 条
[41]   Autologous Stem Cell Transplantation (ASCT) Is Effective Therapy for Older Patients with Non-Hodgkin's Lymphoma (NHL) [J].
Jagadeesh, Deepa ;
Rybicki, Lisa ;
Abounader, Lonna ;
Liu, Hein ;
Dean, Robert M. ;
Hill, Brian T. ;
Sobecks, Ronald M. ;
Gerds, Aaron ;
Hamilton, Betty Ky ;
Pohlman, Brad ;
Kalaycio, Matt E. ;
Bolwell, Brian ;
Majhail, Navneet S. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) :S224-S225
[42]   High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma [J].
Sauerbrey, A ;
Bielack, S ;
Kempf-Bielack, B ;
Zoubek, A ;
Paulussen, M ;
Zintl, F .
BONE MARROW TRANSPLANTATION, 2001, 27 (09) :933-937
[43]   Relapsed Hodgkin lymphoma in adolescents: focus on current high-dose chemotherapy and autologous stem cell transplant [J].
Guilcher, Gregory M. T. ;
Stewart, Douglas A. .
CLINICAL ONCOLOGY IN ADOLESCENTS AND YOUNG ADULTS, 2014, 4 :1-12
[44]   GEMCITABINE, BUSULFAN AND MELPHALAN (Gem/Bu/Mel) IS A NEW HIGH-DOSE CHEMOTHERAPY (HDC) REGIMEN WITH HIGH ACTIVITY IN REFRACTORY OR POOR-RISK RELAPSED NON-HODGKIN'S LYMPHOMA (NHL) PATIENTS RECEIVING AN AUTOLOGOUS STEM-CELL TRANSPLANT (ASCT) [J].
Nieto, Y. ;
Jones, R. B. ;
Popat, U. ;
Andersson, B. ;
Valdez, B. ;
Thall, P. ;
Shpall, E. J. ;
Chancoco, C. ;
Alousi, A. ;
Anderlini, P. ;
Hosing, C. ;
Qazilbash, M. ;
Bashir, Q. ;
Kebriaei, P. ;
Khoui, I ;
Ciurea, S. ;
Parmar, S. ;
Rondon, G. ;
Champlin, R. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) :S206-S206
[45]   High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma [J].
A Sauerbrey ;
S Bielack ;
B Kempf-Bielack ;
A Zoubek ;
M Paulussen ;
F Zintl .
Bone Marrow Transplantation, 2001, 27 :933-937
[46]   High-Dose Therapy and Autologous Stem Cell Transplant (HD-ASCT) for Transformed Non-Hodgkin Lymphoma (NHL) In the Rituximab Era [J].
Ban-Hoefen, Makiko ;
Friedberg, Jonathan W. ;
Kelly, Jennifer L. ;
Bernstein, Steven H. ;
Liesveld, Jane L. ;
Young, Faith ;
Fisher, Richard I. ;
Constine, Louis ;
Becker, Michael ;
Phillips, Gordon L., II .
BLOOD, 2010, 116 (21) :992-992
[47]   Outcome of primary refractory Hodgkin lymphoma with high-dose chemotherapy and autologous stem cell transplantation [J].
Akhtar, S ;
El Weshi, A ;
Rahal, M ;
Abdelsalam, M ;
Janabi, L ;
Hussaini, H ;
Maghfoor, I .
BONE MARROW TRANSPLANTATION, 2006, 37 :S239-S239
[48]   The role of high-dose chemotherapy and autologous stem cell transplantation for relapsed T-cell lymphoma [J].
Kim, S. M. ;
Yoon, D. H. ;
Park, J. H. ;
Koh, G. B. ;
Kim, D. Y. ;
Jung, J. ;
Cho, Y. J. ;
Kim, S. ;
Lee, S. W. ;
Huh, J. ;
Suh, C. .
BONE MARROW TRANSPLANTATION, 2012, 47 :S448-S448
[49]   Pulmonary mortality after high-dose oral busulfan and autologous stem cell transplant (ASCT) in patients with non-Hodgkin lymphoma (NHL). [J].
Kalaycio, M ;
Pohlman, B ;
Rybicki, L ;
Sobecks, R ;
Kuczkowski, E ;
Andresen, S ;
Brown, S ;
Bolwell, B .
BLOOD, 2005, 106 (11) :501A-502A
[50]   BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients [J].
Kim, J. ;
Kim, E. ;
Sohn, B. ;
Yoon, D. ;
Yoo, C. ;
Kim, S. ;
Lee, D. ;
Kim, S. ;
Lee, J. ;
Suh, C. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345